ProCE Banner Activity

Integrating BCMA-Targeted Therapies Into R/R Multiple Myeloma Care: Opportunities for Pharmacists

Slideset

Downloadable slideset from a live webinar on current and emerging BCMA-Targeted therapeutic approaches for the treatment of patients with multiple myeloma

Released: May 03, 2023

Share

Faculty

Donald C. Moore

Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP

Clinical Oncology Pharmacy Manager
Atrium Health Levine Cancer Institute
Charlotte, North Carolina

Victoria R. Nachar

Victoria R. Nachar, PharmD, BCOP

Clinical Pharmacist Specialist
Hematology
University of Michigan Rogel Cancer Center 
Ann Arbor, MI

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Partners

Clinical Care Options, LLC

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

In partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)

Faculty Disclosure

Primary Author

Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP

Clinical Oncology Pharmacy Manager
Atrium Health Levine Cancer Institute
Charlotte, North Carolina

Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP: consultant/advisor/speaker: AstraZeneca, Janssen, Pfizer.

Victoria R. Nachar, PharmD, BCOP

Clinical Pharmacist Specialist
Hematology
University of Michigan Rogel Cancer Center 
Ann Arbor, MI

Victoria Nachar, PharmD, BCOP, has no relevant financial relationships to disclose.